APA

Ziouziou H., Andrieu C., Laurini E., Karaki S., Fermeglia M., Oueslati R., Taieb D., Camplo M., Siri O., Pricl S., Katsogiannou M. & Rocchi P. (092017). Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment. : Oncotarget.

Chicago

Ziouziou Hajer, Andrieu Claudia, Laurini Erik, Karaki Sara, Fermeglia Maurizio, Oueslati Ridha, Taieb David, Camplo Michel, Siri Olivier, Pricl Sabrina, Katsogiannou Maria and Rocchi Palma. 092017. Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment. : Oncotarget.

Harvard

Ziouziou H., Andrieu C., Laurini E., Karaki S., Fermeglia M., Oueslati R., Taieb D., Camplo M., Siri O., Pricl S., Katsogiannou M. and Rocchi P. (092017). Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment. : Oncotarget.

MLA

Ziouziou Hajer, Andrieu Claudia, Laurini Erik, Karaki Sara, Fermeglia Maurizio, Oueslati Ridha, Taieb David, Camplo Michel, Siri Olivier, Pricl Sabrina, Katsogiannou Maria and Rocchi Palma. Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment. : Oncotarget. 092017.